US Patent Issued to Korea Research Institute of Bioscience on Dec. 2 for "Method for producing memory-like NK cells with ability to express higher levels of NCRs, cytotoxicity, and IFN-Gamma than NK cells in human peripheral blood" (South Korean Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,492, issued on Dec. 2, was assigned to Korea Research Institute of Bioscience (Daejeon, South Korea).

"Method for producing memory-like NK cells with ability to express higher levels of NCRs, cytotoxicity, and IFN-Gamma than NK cells in human peripheral blood" was invented by In Pyo Choi (Daejeon, South Korea), Suk Ran Yoon (Daejeon, South Korea), Soo Yeon Park (Daejeon, South Korea), Han Na Kim (Daejeon, South Korea) and Sol Ji Jung (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a method for producing of a memory-like natural killer cell having an ability to produce a higher level of a natural ...